Internationalization

Global Expansion as a Core Strategy

The Company remains committed to independent R&D while actively strengthening international partnerships through open collaboration. In commercialization, we also maintain an open approach.

Currently, multiple products, including injectable and oral formulations, have been launched and sold overseas. The Company also maintains extensive international partnerships in intellectual property licensing.

The Company remains committed to independent R&D while actively strengthening international partnerships through open collaboration. In commercialization, we also maintain an open approach.

Currently, multiple products, including injectable and oral formulations, have been launched and sold overseas. The Company also maintains extensive international partnerships in intellectual property licensing.

30
+
Countries & Regions with Presence
Product Export

Leveraging its strengths and industrial layout, KVVIT Pharmaceutical vigorously promotes its internationalization strategy.

In product export, the Company has formed an international development model: local R&D + global registration + regional production + commercial cooperation.

Intellectual Property Licensing
In-licensing

Focusing on core therapeutic areas, the Company expands its product pipeline by introducing innovative products through in-licensing.

Out-licensing

The Company promotes global access to medical innovations for patients worldwide by out-licensing its proprietary innovative products.

Contact Information